secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0000950170-25-055883
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics appoints Kyle Guse to board; Greg Petersen resigns
--------------------------------------------------------------------

- Kyle Guse appointed to board effective April 18, 2025, filling vacancy from Greg Petersen's resignation.
- Guse named to Audit Committee (Chair) and Compensation Committee; board deemed independent under Nasdaq rules.
- Greg Petersen resigned same day; no disagreement with company operations, policies, or practices.
- Guse is Chief Legal Officer at DDC Enterprise; previously CFO/GC at Atossa Therapeutics.
- Guse brings 30 years of experience in finance, corporate governance, and M&A; will stand for reelection.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000095017025055883/0000950170-25-055883-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000095017025055883/pstv-20250417.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-055883

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer